Income Statement - RECURSION PHARMACEUTICALS, INC. (RXRX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 74.68 | 58.84 | 43.88 | 39.68 | 10.00 | 3.41 | 1.71 |
| Cost of revenue | 120.95 | 45.24 | 42.59 | 48.28 | 9.10 | 63.32 | 45.81 |
| Gross profit | -46.27 | 13.60 | 1.29 | -8.59 | 10.00 | 3.41 | -44.10 |
| Total operating expenses | 601.86 | 492.61 | 351.35 | 237.13 | 192.78 | 88.03 | 64.15 |
| Operating income | -648.13 | -479.00 | -350.06 | -245.73 | -182.78 | -84.62 | -62.44 |
| Non-operating income (net) | 3.24 | 14.22 | 17.93 | 6.25 | -3.70 | -2.39 | 0.56 |
| Income before tax | -644.90 | -464.79 | -332.13 | -239.48 | -186.48 | -87.01 | -61.88 |
| Income tax expense | -0.14 | -1.13 | -4.06 | -0.06 | -8.41 | 0.88 | 0.65 |
| Net income | -644.76 | -463.66 | -328.07 | -239.42 | -178.07 | -87.01 | -62.53 |
Show Quarterly Income Statement
Income Statement - RECURSION PHARMACEUTICALS, INC. (RXRX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.47 | 35.54 | 5.18 | 19.10 | 14.75 | 4.51 | 26.08 | 14.40 | 13.49 | 10.62 | 10.10 | 11.02 | 12.13 | 13.68 | 13.05 | 7.65 | 5.30 | 2.50 | 2.50 | 2.50 | 2.50 | 2.55 | 0.86 | 0.19 | 0.06 |
| Cost of revenue | 12.49 | 26.88 | 29.59 | 20.16 | 21.83 | 12.79 | 12.08 | 9.20 | 11.17 | 9.88 | 10.88 | 9.38 | 12.45 | 10.84 | 15.41 | 14.23 | 7.80 | 2.58 | 33.25 | 29.62 | 24.11 | 20.70 | 16.54 | 13.24 | 12.84 |
| Gross profit | -6.02 | 8.66 | -24.42 | -1.06 | -7.08 | -8.28 | 14.00 | 5.21 | 2.33 | 0.74 | -0.78 | 1.63 | -0.31 | 2.84 | -2.36 | -6.57 | -2.50 | 2.50 | 2.50 | 2.50 | 2.50 | 2.55 | 0.86 | -13.06 | -12.78 |
| Total operating expenses | 122.49 | 117.00 | 147.78 | 175.17 | 184.28 | 175.49 | 112.36 | 105.75 | 98.67 | 99.67 | 98.78 | 83.35 | 69.55 | 63.82 | 60.22 | 59.62 | 53.48 | 67.46 | 48.90 | 43.43 | 32.98 | 28.13 | 23.34 | 18.22 | 18.34 |
| Operating income | -128.51 | -108.33 | -172.20 | -176.23 | -191.37 | -183.77 | -98.35 | -100.54 | -96.34 | -98.93 | -99.55 | -81.72 | -69.87 | -60.98 | -62.57 | -66.19 | -55.98 | -64.96 | -46.40 | -40.93 | -30.48 | -25.58 | -22.47 | -18.22 | -18.34 |
| Non-operating income (net) | 6.40 | 0.23 | 9.95 | 4.33 | -11.28 | 4.87 | 2.68 | 2.48 | 4.19 | 1.87 | 6.53 | 4.99 | 4.54 | 3.49 | 2.13 | 0.63 | 0.00 | 0.03 | -1.03 | -2.47 | -0.23 | -0.19 | -1.40 | -0.73 | -0.08 |
| Income before tax | -122.11 | -108.10 | -162.25 | -171.90 | -202.65 | -178.90 | -95.68 | -98.06 | -92.15 | -97.06 | -93.02 | -76.73 | -65.33 | -57.49 | -60.45 | -65.56 | -55.98 | -64.93 | -47.43 | -43.40 | -30.72 | -25.77 | -23.87 | -18.94 | -18.42 |
| Income tax expense | -4.60 | 0.02 | 0.00 | -0.16 | 0.01 | 0.17 | -0.52 | -0.78 | -4.06 | 1.61 | -5.54 | -4.54 | -0.01 | -2.13 | -0.01 | 0.00 | 0.02 | 1.03 | 2.47 | 0.23 | -0.48 | 1.40 | 0.73 | 0.08 | |
| Net income | -117.50 | -108.12 | -162.25 | -171.90 | -202.49 | -178.91 | -95.68 | -97.54 | -91.37 | -93.00 | -93.02 | -76.73 | -65.33 | -57.49 | -60.45 | -65.56 | -55.98 | -64.93 | -47.43 | -43.40 | -30.72 | -25.77 | -23.87 | -18.94 | -18.42 |